Responses
Pancreatic cancer
A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study
Compose a Response to This Article
Other responses
No responses have been published for this article.